Purchases and Sales Made in Q3 2023 in Cogent Biosciences, Inc. (COGT)
This table provides information about the institutional ownership of Cogent Biosciences, Inc. (COGT) during Q3 2023. The information is specifically focused on institutions that hold shares of Cogent Biosciences, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-74.2K- 55.03% |
$719K - $989K
|
60.6K
$561K
|
|
Nov 06, 2023
Q3 2023
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-89.4K- 12.8% |
$866K - $1.19M
|
609K
$5.63M
|
|
Nov 14, 2023
Q3 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-91.6K- 45.33% |
$888K - $1.22M
|
111K
$1.02M
|
|
Nov 14, 2023
Q3 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-100K- 8.8% |
$969K - $1.33M
|
1.04M
$9.58M
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-160K- 5.13% |
$1.55M - $2.14M
|
2.97M
$27.5M
|
|
Nov 14, 2023
Q3 2023
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-350K- 13.16% |
$3.39M - $4.67M
|
2.31M
$21.4M
|
|
Nov 14, 2023
Q3 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-918K- 19.6% |
$8.9M - $12.3M
|
3.77M
$34.8M
|
|
Nov 14, 2023
Q3 2023
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-1.29M- 37.51% |
$12.5M - $17.2M
|
2.15M
$19.9M
|
|
Nov 14, 2023
Q3 2023
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-2.28M- 67.64% |
$22.1M - $30.4M
|
1.09M
$10.1M
|